2
Registered trials
1
Recruiting
2
Unique sponsors
2
Unique IMPs
1
Commercial trials
Drug classes (ATC)
—
ATC code not specified
1
S
Ophthalmology/ENT (ATC S)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
1 substance
Receptor fusion protein
1 substance
Phase III:
2
Phase III
2 trials-
RecruitingAura Biosciences Inc. CommercialBELZUPACAP SAROTALOCAN
-
EndedCentre Hospitalier Universitaire De Nantes AcademicAFLIBERCEPT
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Aura Biosciences Inc. | Commercial | 1 | Phase III | 1 |
| Centre Hospitalier Universitaire De Nantes | Academic | 1 | Phase III | 0 |
New trials by year
2024
1